Global Magnetic Resonance Imaging Contrast Media Market Growth 2023-2029

Global Magnetic Resonance Imaging Contrast Media Market Growth 2023-2029

Contrast agents, also called contrast media, are substances used to enhance the radiodensity of a targeted tissue by altering the way that electromagnetic radiation or ultrasound waves pass through the body. These substances can be administered to the patient orally, rectally, or intravenously.

LPI (LP Information)' newest research report, the “Magnetic Resonance Imaging Contrast Media Industry Forecast” looks at past sales and reviews total world Magnetic Resonance Imaging Contrast Media sales in 2022, providing a comprehensive analysis by region and market sector of projected Magnetic Resonance Imaging Contrast Media sales for 2023 through 2029. With Magnetic Resonance Imaging Contrast Media sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Magnetic Resonance Imaging Contrast Media industry.

This Insight Report provides a comprehensive analysis of the global Magnetic Resonance Imaging Contrast Media landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Magnetic Resonance Imaging Contrast Media portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Magnetic Resonance Imaging Contrast Media market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Magnetic Resonance Imaging Contrast Media and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Magnetic Resonance Imaging Contrast Media.

The global Magnetic Resonance Imaging Contrast Media market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Magnetic Resonance Imaging Contrast Media is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Magnetic Resonance Imaging Contrast Media is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Magnetic Resonance Imaging Contrast Media is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Magnetic Resonance Imaging Contrast Media players cover Jiangsu Hengrui Medicine Co.,Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., Ge Healthcare Shanghai Co., Ltd., BAYER, Shanghai Bracco Sine Pharmaceutical Co., Ltd., Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd., Beijing Beilu Pharmaceutical Co.,Ltd., Starry Pharmaceutical and Guerbet, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Magnetic Resonance Imaging Contrast Media market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Iodine Based
Barium Sulfate Compounds

Segmentation by application
Hospitals
Clinics
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Jiangsu Hengrui Medicine Co.,Ltd.
Yangtze River Pharmaceutical (Group) Co., Ltd.
Ge Healthcare Shanghai Co., Ltd.
BAYER
Shanghai Bracco Sine Pharmaceutical Co., Ltd.
Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
Beijing Beilu Pharmaceutical Co.,Ltd.
Starry Pharmaceutical
Guerbet

Key Questions Addressed in this Report

What is the 10-year outlook for the global Magnetic Resonance Imaging Contrast Media market?

What factors are driving Magnetic Resonance Imaging Contrast Media market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Magnetic Resonance Imaging Contrast Media market opportunities vary by end market size?

How does Magnetic Resonance Imaging Contrast Media break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.